GGrantIndex
← Leaderboards

Andrew Martin Rollins

Case Western Reserve University

$14,153,737
Attributed
$20,573,979
Total exposure
11
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$20,573,979 · 11

By mechanism

R01$18,603,260 · 8
D43$985,849 · 1
R21$984,870 · 2

Top collaborators

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Technology

Research focus

TechnologyOpticsImageBaseStructureMapsTissuesPropertyIn VivoCardiacOptical Coherence TomographyMeasurementValidationDesignAlgorithmsProceduresShapesPatternScanningSuccessFamily SuidaeHeartResolutionStaging

Grant awards (45)

5 D impulse mapping in the embryonic heart$681,588
R01 · FY2025 · HL · contact PI
Advanced Imaging and Simulation Tools for Personalized Corneal Disease Assessment and Surgery$608,199
R01 · FY2025 · EY
Strengthening Research Capacity in Innovative Global Health Technologies for Non-Communicable Diseases in Uganda$246,419
D43 · FY2025 · TW · contact PI
5 D impulse mapping in the embryonic heart$674,167
R01 · FY2024 · HL · contact PI
Advanced Imaging and Simulation Tools for Personalized Corneal Disease Assessment and Surgery$608,199
R01 · FY2024 · EY
Strengthening Research Capacity in Innovative Global Health Technologies for Non-Communicable Diseases in Uganda$246,449
D43 · FY2024 · TW · contact PI
5 D impulse mapping in the embryonic heart$710,910
R01 · FY2023 · HL · contact PI
Advanced Imaging and Simulation Tools for Personalized Corneal Disease Assessment and Surgery$625,909
R01 · FY2023 · EY
Strengthening Research Capacity in Innovative Global Health Technologies for Non-Communicable Diseases in Uganda$246,477
D43 · FY2023 · TW · contact PI
Optically guided catheter ablation of atrial fibrillation$681,670
R01 · FY2022 · HL · contact PI
Advanced Imaging and Simulation Tools for Personalized Corneal Disease Assessment and Surgery$612,661
R01 · FY2022 · EY
Noninvasive assessment of the cornea by diffusion OCT$379,704
R01 · FY2022 · EY · contact PI
Strengthening Research Capacity in Innovative Global Health Technologies for Non-Communicable Diseases in Uganda$246,504
D43 · FY2022 · TW · contact PI
Optically guided catheter ablation of atrial fibrillation$683,321
R01 · FY2021 · HL · contact PI
Noninvasive assessment of the cornea by diffusion OCT$381,543
R01 · FY2021 · EY · contact PI
Optically guided catheter ablation of atrial fibrillation$709,225
R01 · FY2020 · HL · contact PI
Noninvasive assessment of the cornea by diffusion OCT$391,938
R01 · FY2020 · EY · contact PI
Optically guided catheter ablation of atrial fibrillation$767,419
R01 · FY2019 · HL · contact PI
Noninvasive assessment of the cornea by diffusion OCT$396,887
R01 · FY2019 · EY · contact PI
Noninvasive assessment of the cornea by diffusion OCT$400,000
R01 · FY2018 · EY · contact PI
In vivo Characterization of Stents using Intravascular OCT Imaging$447,440
R01 · FY2016 · HL
Integrated imaging of the form and function of the beating embryonic heart$356,784
R01 · FY2016 · HL · contact PI
Cardiac radiofrequency ablation catheter with integrated OCT imaging$237,750
R21 · FY2016 · HL · contact PI
In vivo Characterization of Stents using Intravascular OCT Imaging$457,216
R01 · FY2015 · HL
Integrated imaging of the form and function of the beating embryonic heart$359,023
R01 · FY2015 · HL · contact PI
Cardiac radiofrequency ablation catheter with integrated OCT imaging$198,125
R21 · FY2015 · HL · contact PI
In vivo Characterization of Stents using Intravascular OCT Imaging$402,534
R01 · FY2014 · HL
Integrated imaging of the form and function of the beating embryonic heart$373,641
R01 · FY2014 · HL · contact PI
Integrated imaging of the form and function of the beating embryonic heart$620,585
R01 · FY2013 · HL · contact PI
In vivo Characterization of Stents using Intravascular OCT Imaging$412,883
R01 · FY2013 · HL
Staging of upper tract urothelial cancer with optical coherence tomography$244,983
R21 · FY2013 · CA · contact PI
Investigating the Early Embryonic Murine Heart Using Optical Coherence Tomography$712,087
R01 · FY2012 · HL · contact PI
Staging of upper tract urothelial cancer with optical coherence tomography$304,012
R21 · FY2012 · CA · contact PI
Investigating the Early Embryonic Murine Heart Using Optical Coherence Tomography$720,137
R01 · FY2011 · HL · contact PI
Investigating the Early Embryonic Murine Heart Using Optical Coherence Tomography$758,073
R01 · FY2010 · HL · contact PI
Investigating the Early Embryonic Murine Heart Using Optical Coherence Tomography$774,170
R01 · FY2009 · HL · contact PI
OCT Imaging Technology for Developmental Cardiology Research$371,408
R01 · FY2009 · HL · contact PI
Endoscopic OCT Imaging Technology for Surveillance$286,517
R01 · FY2009 · CA · contact PI
OCT Imaging Technology for Developmental Cardiology Research$371,408
R01 · FY2008 · HL · contact PI
Endoscopic OCT Imaging Technology for Surveillance$286,517
R01 · FY2008 · CA · contact PI
OCT Imaging Technology for Developmental Cardiology Research$351,671
R01 · FY2007 · HL · contact PI
Endoscopic OCT Imaging Technology for Surveillance$286,517
R01 · FY2007 · CA · contact PI
OCT Imaging Technology Developmental Cardiology Research$360,982
R01 · FY2006 · HL · contact PI
Endoscopic OCT Imaging Technology for Surveillance$295,074
R01 · FY2006 · CA · contact PI
Endoscopic OCT Imaging Technology for Surveillance$285,253
R01 · FY2005 · CA